| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0003 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0003 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0004 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0006 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
SZ4TA2 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.001 |
| mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |